RXi Pharmaceuticals Enters into Common Stock Purchase Agreement for Up to $15.0 Million


MARLBOROUGH, Mass., Aug. 9, 2017 /PRNewswire/  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical needs, today announced that it has entered into a common stock purchase agreement with Lincoln Park Capital Fund, LLC (LPC).  LPC is a long-only, Chicago-based investor with a portfolio emphasis in life sciences, including therapeutics being [ ] The post RXi Pharmaceuticals Enters into Common Stock Purchase Agreement for Up to $15.0 Million appeared first on STL News.
http://bit.ly/2uoUNK6

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Create a website or blog at WordPress.com

Up ↑

%d bloggers like this: